Replimune Group, Inc. (REPL)
NASDAQ·Healthcare·Biotechnology
$5.24
-2.15%
Mkt Cap $878.07M
Analyst Ratings
Buy
2
Hold
5
Sell
2
Price Target (15 analysts)
$14.00
Range $14.00 – $14.00
Implied Upside
+167.4%
Consensus $14.00 vs current $5.24
NASDAQ·Healthcare·Biotechnology
$5.24
-2.15%
Mkt Cap $878.07M
Buy
2
Hold
5
Sell
2
Price Target (15 analysts)
$14.00
Range $14.00 – $14.00
+167.4%
Consensus $14.00 vs current $5.24